3E Bioventures
5AM Ventures 82VS Accequa AB age1 Fund I GP, LLC Agile Capital Markets AGTC Ventures LLC Alpha Bronze Alta Global Ventures Andera Partners Angelini Ventures Aqua Partners LLC Argobio Studio ATEM Capital Avestria Ventures BERNINA BioInvest Ltd. Bioqube Ventures Bioscience Managers Pty Ltd BIOSTART Consulting GmbH Blackstone Life Sciences Bradley Woods & Co. Ltd. Brandon Capital BTIG, LLC Cantor Fitzgerald Capital Family Office Cassel Salpeter & Co., LLC CBT Advisors China Grand Enterprises, Inc. Class Bravo Ventures Cota Capital Crosswave Management, Inc. CTI Life Sciences Cukierman & Co. Investment House Ltd. Cukierman & Co. Life Sciences David Fox Syndicate DCVC Bio Deerfield Management DEFTA Partners DigiTx Partners Dorset Capital LLC Droia Ventures EF Hutton Eight Roads Ventures Eli Lilly and Company EQT Life Sciences F. Hoffmann-La Roche Ltd. Ferghana Partners, Inc. Forbion Forty51 Ventures Fraser Finance LLP Freedom Capital Markets Generation Fund Life Sciences Fund I Gimv Global Emerging Markets (GEM) Good Health Capital GreenSky Capital, Inc. H.C. Wainwright & Co. Hatteras Venture Partners HBM Partners AG Health Innovation Capital Hestia Investments Ltd. High-Tech Gründerfonds Management GmbH Hunniwell Lake Ventures LLC Ignite Capital Partners, Inc. Illumina Accelerator Illumina Ventures Impact India Investment Partners, LLC Indaco Venture Partners SGR S.p.A. Independent Intermediate Capital Group PLC Inveready Asset Management IPF Management S.A. Jeito Capital Johnson & Johnson Innovation – JJDC, Inc. Johnston Associates JPMorgan Chase & Co. Last updated on: 3rd of January
|
Kaleida Capital
Katan Associates Korys Investments NV Ladenburg Thalmann & Co. Inc. Landmark Angels, Inc. Leaps by Bayer Lilly Asia Ventures LongeVC Lucia Capital Lumira Ventures Lundbeckfonden BioCapital Ventures M Ventures Mass General Brigham Ventures Mid Atlantic Bio Angels MUFG Union Bank, N.A. New Harbor Venture Partners, LLC New Science Global Healthcare Fund Noble Life Science Partners Novartis AG Novo Holdings Oceaniq Capital Ontario Brain Institute Ontario Teachers' Pension Plan Board Oppenheimer & Co. Inc. Optimum Strategic Communications OrbiMed Advisors LLC Osage University Partners Palo Alto Investors Panakès Partners SGR SpA Pappas Capital Perceptive Advisors, LLC PJT Partners Prevail Partners LLC Profound Ventures Pureos Bioventures Qiming Venture Partners Raya Therapeutic re.Mind Capital Ltd. Recode Health Ventures Remiges Ventures, Inc. Roth Capital Partners, LLC RYSE Asset Management Sand Hill Angels Sandman Financial Seventure Partners Shadow Lake Group Inc. Silicon Valley Bank Silicon Valley Ventures Sixty Degree Capital Sofinnova Investments, Inc. Sofinnova Partners Sony Innovation Fund Sound Bioventures Management AB SR One SternAegis Ventures Stifel Europe SV Health Investors LLP Talu Ventures The Benchmark Company, LLC Torreya Treo Ventures TruVenturo GmbH Twin Oaks Capital, LLC V-Bio Ventures Valor Management S.A. Ventac Partners A/S Venture Valuation Vine Ventures Real LLC Vista Capital Advisors, LLC WBB Securities, LLC Wellington Partners Wells Fargo Bank N.A. WPSS.bio WRF Capital XOventure GmbH More TBA... |
6TH ANNUAL NEUROSCIENCE INNOVATION FORUM
FOR BUSINESS DEVELOPMENT, LICENSING & INVESTMENT
8TH JANUARY 2023 | MARINES' MEMORIAL CLUB | SAN FRANCISCO | USA
INVESTORS AT THE #Sachs_NIF FORUM
Sachs Associates Switzerland AG
|
Sachs Associates Ltd.
|
T: +44 203 463 4890
E: [email protected]
© COPYRIGHT 2023. ALL RIGHTS RESERVED.